A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
about
Survivin: a unique target for tumor therapySafety of targeting tumor endothelial cell antigensTargeted Cancer Therapy Using Engineered Salmonella typhimuriumSurvivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancerModified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markersDNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.Vaccines targeting the neovasculature of tumorsThe prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus.Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™.Role of the Survivin gene in pathophysiologySurvivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure.A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner.Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaCancer gene therapy targeting angiogenesis: an updated review.Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral gliomaCancer treatment: the combination of vaccination with other therapies.Human survivin and Trypanosoma cruzi calreticulin act in synergy against a murine melanoma in vivo.Therapeutic cancer vaccines in combination with conventional therapy.Survivin as a preferential target for cancer therapy.Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line.Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.Tumor-associated antigens for specific immunotherapy of prostate cancerEfficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice.
P2860
Q26747332-572165DE-E15B-4DC4-A50A-C1414344B053Q26748863-1C0EB9B8-D4BE-463E-9E6C-FF94AF534337Q28069354-8C2CD770-D218-4177-8BCD-F2DF266B8D55Q28306223-2049BBC1-CB5F-44B8-8CFE-782FEAB73674Q33723063-3A031832-C9AB-4C81-8F3B-247B45C14065Q33745108-084D3F3C-721F-4966-A989-1E41066BD97CQ33911460-92AF38A4-FE36-42E9-9206-631F94FE215CQ34357503-B8EC4604-E83E-47AD-884C-191CAE97BE48Q34704905-4484AE3D-561D-44F5-84A7-F3AF3D938C1EQ35000726-F66CCF74-10F0-42C7-9B68-49E1F05BD25FQ35114611-F7D18CE7-658C-4BA5-AB37-144A6B439A85Q35187503-ADF1E2C4-EF0F-4096-9ED2-85855786936EQ35221844-B0AC65EA-C785-4BF3-9221-CC37165BC824Q35623772-82DB40E2-F886-40A0-9FE1-C3510BE55066Q35828837-B3D278F6-AF0D-46D6-BD3D-1F27BE7003F6Q35849588-CD7CF13E-107F-443D-9E68-180406FB858DQ36384615-10438FF1-5EFF-4B8E-BA27-ABAD5200EDA0Q36384933-F9DA42EC-DF34-4F8F-94E4-2D9888FE019EQ36655133-FC07557F-AEB9-4A42-8EA3-04C50692B15EQ36725286-68857C8D-F938-44E9-9B21-C8A9E6292CF1Q36948849-B10D7F3B-57F1-4076-85DD-4FC9B5383FF5Q37089001-E660918F-7B7E-4BFF-9BA9-CB569EFBACA9Q37716777-0CC5E18D-8452-4E20-97DE-CBDAA70359B5Q37771267-BBEC2B02-3178-49B9-8EFF-E5C74B624604Q38188377-DB98A7D3-E2CC-415D-BF8F-F1419EE790B9Q39888963-B9B0926E-25B3-484E-A563-BDF9B65EB6E9Q41503180-49829881-BD8C-42DD-A2BB-12D637FE89BBQ41956511-D142C4B0-708A-4812-8589-B30DDEEFE3B3Q41977894-9BF201CB-22BB-4E31-9059-58F773A027FFQ47845243-3DB483D7-F5A4-4A63-88B8-BD188183E387
P2860
A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@ast
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@en
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@nl
type
label
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@ast
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@en
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@nl
prefLabel
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@ast
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@en
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@nl
P2093
P3181
P1433
P1476
A DNA vaccine targeting surviv ...... esis in lung tumor eradication
@en
P2093
Claudia Chiodoni
Juergen C Becker
Masato Mizutani
Noriko Mizutani
Ralph A Reisfeld
Rong Xiang
Yunping Luo
P304
P3181
P407
P577
2005-01-15T00:00:00Z